1988
DOI: 10.1289/ehp.8877151
|View full text |Cite
|
Sign up to set email alerts
|

The in vitro serum protein-binding characteristics of bis-(2-ethylhexyl) phthalate and its principal metabolite, mono-(2-ethylhexyl) phthalate.

Abstract: The metabolism and toxicity of the ubiquitous plasticizer, bis-(2-ethylhexyl) phthalate (DEHP), and its principal metabolite, mono-(2-ethylhexyl) phthalate (MEHP), have been extensively investigated. In an attempt to understand their disposition in man, we studied the in vitro serum protein-binding characteristics of these compounds, using ultracentrifugation and agarose gel electrophoresis. The association of DEHP and lipoproteins was shown to be highly dependent upon, and proportional to, the lipid concentra… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
12
0

Year Published

1991
1991
2020
2020

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 25 publications
(12 citation statements)
references
References 25 publications
0
12
0
Order By: Relevance
“…MEHP accumulation is of concern because MEHP is 20 times more toxic than DEHP in rats 11. Additionally, MEHP has a longer plasma half-life due to its ability to bind to serum proteins, specifically to human serum albumin 12,13. Due to its lipophilic characteristics, DEHP also exerts many biochemical effects such as decreasing its own metabolism by inhibiting serum arylesterase activity levels 14.…”
Section: Discussionmentioning
confidence: 99%
“…MEHP accumulation is of concern because MEHP is 20 times more toxic than DEHP in rats 11. Additionally, MEHP has a longer plasma half-life due to its ability to bind to serum proteins, specifically to human serum albumin 12,13. Due to its lipophilic characteristics, DEHP also exerts many biochemical effects such as decreasing its own metabolism by inhibiting serum arylesterase activity levels 14.…”
Section: Discussionmentioning
confidence: 99%
“…MEHP is negatively charged and by that cannot be taken up into the cells in an in vitro model cultured without fetal calf serum (FCS) 80 , 81 . Moreover, the systemic availability of DEHP is 50–100 times higher in humans than in marmosets and rodents 20 .…”
Section: Methodsmentioning
confidence: 99%
“…Besides this, DEHP exposure has been correlated with metabolic disorders mainly via the PPAR signaling pathway. A study by Griffiths et al (1988) showed that DEHP partly binds to lipoproteins as well as lipids, owing to its lipophilic character. In this study we used DEHP instead of the active metabolite MEHP.…”
Section: Discussionmentioning
confidence: 99%
“…They have different lipophilic characteristics and they differ in bioavailibilty. A study by Griffiths et al (1988) showed that DEHP partly binds to lipoproteins as well as lipids, owing to its lipophilic character. MEHP has diminished lipid solubility due to its free carboxyl group and greater polarity, and binds to albumin analogues.…”
Section: Discussionmentioning
confidence: 99%